The reaction and -27% IS concerning and annoying, but I was a buyer today.
I see nothing wrong with NVTR, either with their product or their steady increases in local markets; ie, increasing number of surgeons using their product.
They have a ways to go, and against companies with larger pockets.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.